Standout Papers

EPA guidance on assessment o... 2009 2026 2014 2020 1.1k
  1. EPA guidance on assessment of negative symptoms in schizophrenia (2021)
    Silvana Galderisi, Armida Mucci et al. European Psychiatry
  2. Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors (2022)
    Christoph U. Correll, Marco Solmi et al. World Psychiatry
  3. Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression (2023)
    Andreas Reif, István Bitter et al. New England Journal of Medicine
  4. EPA guidance on treatment of negative symptoms in schizophrenia (2021)
    Silvana Galderisi, Stefan Kaiser et al. European Psychiatry
  5. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis (2009)
    Viktória Simon, Pál Czobor et al. The British Journal of Psychiatry

Immediate Impact

2 by Nobel laureates 3 from Science/Nature 65 standout
Sub-graph 1 of 21

Citing Papers

Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases
2024 Standout
Infant microbes and metabolites point to childhood neurodevelopmental disorders
2024 Standout
14 intermediate papers

Works of István Bitter being referenced

Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis
2009 Standout
Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis
2009
and 1 more

Author Peers

Author Last Decade Papers Cites
István Bitter 3539 1439 939 152 4.8k
Susan K. Schultz 2445 978 848 137 5.3k
H.‐J. Möller 2348 747 663 137 4.1k
Sonia Dollfus 2906 1484 696 184 4.4k
Thomas Wobrock 2405 1500 812 123 4.7k
John Lauriello 2022 1838 971 94 4.7k
Robert Goldman 3801 1355 1118 99 5.2k
Alkomiet Hasan 2183 1874 1047 205 5.8k
David Healy 1809 971 1372 179 4.9k
A. Carlo Altamura 2768 747 1278 171 5.0k
Rosemary Toomey 2349 1254 1263 106 4.9k

All Works

Loading papers...

Rankless by CCL
2026